By Medifit Biologicals




An antibiotic sensitivity (or susceptibility) test is done to help choose the antibiotic that will be most effective against the specific types of bacteria or fungus infecting an individual person.

Some types of bacteria or fungus are resistant to certain antibiotics because of differences in their genetic material (genes). Infections caused by resistant bacteria or fungi are not cured by treatment with those antibiotics.

Drug-resistant bacteria or fungi usually develop because the entire course of antibiotic treatment was not completed. Stopping drug treatment early kills only the bacteria or fungi that are sensitive to the drugs, allowing the resistant bacteria or fungi to multiply and cause an infection.



A thorough exam and appropriate diagnostic tests are essential for an accurate diagnosis. Research has suggested that drug allergies may be over diagnosed and that patients may report drug allergies that have never been confirmed. Misdiagnosed drug allergies may result in the use of less appropriate or more expensive drugs.

Your doctor will conduct a physical examination and ask you questions. Details about the onset of symptoms, the time you took medications, and improvements or worsening of symptoms are important clues for helping your doctor make a diagnosis.

Your doctor may order additional tests or refer you to an allergy specialist (allergist) for tests. These may include the following.



With a skin test, the allergist or nurse administers a small amount of a suspect drug to your skin either with a tiny needle that scratches the skin, an injection or a patch. A positive reaction to a test will cause a red, itchy, raised bump.

A positive result almost always indicates a drug allergy. A negative result is more difficult to interpret because of differences in the reliability of tests. For some drugs, a negative test result usually means that you’re not allergic to the drug. For other drugs, a negative result may not rule out the possibility of a drug allergy.



Your doctor may order blood work to rule out other conditions that could be causing signs or symptoms.

While there are blood tests for detecting allergic reaction to a few drugs, these tests aren’t used often because of the relatively limited research on their accuracy. They may be used if there’s concern about a severe reaction to a skin test.


Results of diagnostic workup

When your doctor analyzes your symptoms and test results, he or she can usually reach one of the following conclusions:

  • You have a drug allergy
  • You don’t have a drug allergy
  • You may have a drug allergy — with varying degrees of certainty

These conclusions can help your doctor and you in making future treatment decisions.





The Broth dilution method involves subjecting the isolate to a series of concentrations of antimicrobial agents in a broth environment.   Microdilution testing uses about 0.05 to 0.1 ml total broth volume and can be conveniently performed in a microtiter format.  Macrodilution testing uses broth volumes at about 1.0 ml in standard test tubes.  For both of these broth dilution methods, the lowest concentration at which the isolate is completely inhibited (as evidenced by the absence of visible bacterial growth) is recorded as the minimal inhibitory concentration or MIC.  The MIC is thus the minumum concentration of the antibiotic that will inhibit this particular isolate.  The test is only valid if the positive control shows growth and the negative control shows no growth.


A procedure similar to broth dilution is agar dilution.  Agar dilution method follows the principle of establishing the lowest concentration of the serially diluted antibiotic concentration at which bacterial growth is still inhibited.



Because of convenience, efficiency and cost, the disk diffusion method is probably the most widely used method for determining antimicrobial resistance in private veterinary clinics.

A growth medium, usually Mueller-Hinton agar, is first evenly seeded throughout the plate with the isolate of interest that has been diluted at a standard concentration (approximately 1 to 2 x 108 colony forming units per ml).  Commercially prepared disks, each of which are pre-impregnated with a standard concentration of a particular antibiotic, are then evenly dispensed and lightly pressed onto the agar surface.  The test antibiotic immediately begins to diffuse outward from the disks, creating a gradient of antibiotic concentration in the agar such that the highest concentration is found close to the disk with decreasing concentrations further away from the disk. After an overnight incubation, the bacterial growth around each disc is observed.  If the test isolate is susceptible to a particular antibiotic, a clear area of “no growth” will be observed around that particular disk.

The zone around an antibiotic disk that has no growth is referred to as the zone of inhibition since this approximates the minimum antibiotic concentration sufficient to prevent growth of the test isolate.  This zone is then measured in mm and compared to a standard interpretation chart used to categorize the isolate as susceptible, intermediately susceptible or resistant.  MIC measurement cannot be determined from this qualitative test, which simply classifies the isolate as susceptible, intermediate or resistant.


  1. E-TEST

E-test (AB Biodisk, Solna, Sweden) is a commercially available test that utilizes a plastic test strip impregnated with a gradually decreasing concentration of a particular antibiotic.  The strip also displays a numerical scale that corresponds to the antibiotic concentration contained therein. This method provides for a convenient quantitative test of antibiotic resistance of a clinical isolate.  However, a separate strip is needed for each antibiotic, and therefore the cost of this method can be high.



Several commercial systems have been developed that provide conveniently prepared and formatted microdilution panels as well as instrumentation and automated reading of plates.  These methods are intended to reduce technical errors and lengthy preparation times.


Most automated antimicrobial susceptibility testing systems provide automated inoculation, reading and interpretation.  These systems have the advantage of being rapid (some results can be generated within hours) and convenient, but one major limitation for most laboratories is the cost entailed in initial purchase, operation and maintenance of the machinery.  Some examples of these include: Vitek System (bioMerieux, France), Walk-Away System (Dade International, Sacramento, Calif.), Sensititre ARIS (Trek Diagnostic Systems, East Grinstead, UK), Avantage Test System (Abbott Laboratories,  Irving, Texas), Micronaut (Merlin, Bornheim-Hesel, Germany), Phoenix  (BD Biosciences, Maryland) and many more.



Resistance may also be established through tests that directly detect the presence of a particular resistance mechanism.  For example, beta lactamase detection can be accomplished using an assay such as the chromogenic cephalosporinase test (Cefinase disk by BD Microbiology Systems, Cockeysville, MD and BBL DrySlide Nitrocefin, Becton Dickinson, Sparks, MD) and detection for chloramphenicol modifying enzyme chloramphenicol acetyltransferase (CAT) may utilize commercial colorimetric assays such as a CAT reagent kit (Remel, Lenexa, Kansas).



Since resistance traits are genetically encoded, we can sometimes test for the specific genes that confer antibiotic resistance.  However, although nucleic acid-based detections systems are generally rapid and sensitive, it is important to remember that the presence of a resistance gene does not necessarily equate to treatment failure, because resistance is also dependent on the mode and level of expression of these genes11.

Some of the most common molecular techniques utilized for antimicrobial resistance detection are as follows

Polymerase chain reaction (PCR) is one of the most commonly used molecular techniques for detecting certain DNA sequences of interest.  This involves several cycles of denaturation of sample DNA, annealing of specific primers to the target sequence (if present), and the extension of this sequence as facilitated by a thermostable polymerase leading to replication of a duplicate DNA sequence, in an exponential manner, to a point which will be visibly detectable by gel electrophoresis with the aid of a DNA-intercalating chemical which fluoresces under UV light.

DNA hybridization. This is based on the fact that the DNA pyrimidines (cytosine and thymidine) specifically pair up with purines (guanine and adenine; or uracil for RNA).  Therefore, a labeled probe with a known specific sequence can pair up with opened or denatured DNA from the test sample, as long as their sequences complement each other.  If this “hybridization” occurs, the probe labels this with a detectable radioactive isotope, antigenic substrate, enzyme or chemiluminescent compound.  Whereas if no target sequence is present or the isolate does not have the specific gene of interest, no attachment of probes will occur, and therefore no signals will be detected.

Modifications of PCR and DNA hybridization.  With these basic principles, several modifications have been introduced which further improve the sensitivity and specificity of these standard procedures.  Examples of such development were the use of 5’-fluorescence-labeled oligonucleotides, the development of molecular beacons, development of DNA arrays and DNA chips, among many others.

By Medifit Biologicals